Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.510
-0.080 (-3.09%)
At close: Jan 30, 2026, 4:00 PM EST
2.500
-0.010 (-0.40%)
After-hours: Jan 30, 2026, 7:58 PM EST
Cronos Group Market Cap
Cronos Group has a market cap or net worth of $959.77 million as of January 30, 2026. Its market cap has increased by 26.80% in one year.
Market Cap
959.77M
Enterprise Value
166.10M
1-Year Change
26.80%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since February 27, 2018, Cronos Group's market cap has decreased from $1.14B to $959.77M, a decrease of -15.67%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 961.10M | -4.56% |
| Dec 31, 2025 | 1.01B | 30.41% |
| Dec 31, 2024 | 772.20M | -3.05% |
| Dec 29, 2023 | 796.50M | -17.14% |
| Dec 30, 2022 | 961.30M | -34.04% |
| Dec 31, 2021 | 1.46B | -41.04% |
| Dec 31, 2020 | 2.47B | -6.25% |
| Dec 31, 2019 | 2.64B | 42.01% |
| Dec 31, 2018 | 1.86B | 63.14% |
| Feb 27, 2018 | 1.14B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow | 1.55B |
| Collegium Pharmaceutical | 1.43B |
| Evotec SE | 1.33B |
| Amphastar Pharmaceuticals | 1.20B |
| Tilray Brands | 887.78M |
| Pacira BioSciences | 864.30M |
| Esperion Therapeutics | 835.78M |
| BioAge Labs | 797.47M |